Submitted by Anonymous (not verified) on 5 February 2025 - 15:12
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 34, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Apidra, insulin glulisine, Date of authorisation: 27/09/2004, Revision: 34, Status: Authorised